$6.97 Billion is the total value of Bellevue Group AG's 217 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 11.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IONS | Sell | IONIS PHARMACEUTICALS INC | $418,566,000 | +15.6% | 9,463,400 | -3.2% | 6.01% | +17.4% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $335,323,000 | +1.2% | 1,158,126 | -1.5% | 4.81% | +2.7% |
| ARGX | Sell | ARGENX SEsponsored adr | $331,858,000 | -5.1% | 919,346 | -1.5% | 4.76% | -3.6% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $191,505,000 | +24.1% | 956,762 | -9.6% | 2.75% | +25.9% |
| MRNA | Sell | MODERNA INC | $184,447,000 | -18.1% | 1,559,801 | -1.1% | 2.65% | -16.9% |
| INCY | Sell | INCYTE CORP | $182,878,000 | -13.2% | 2,744,277 | -1.0% | 2.62% | -11.9% |
| ISRG | Sell | INTUITIVE SURGICAL INC | $168,338,000 | -7.8% | 898,092 | -1.2% | 2.42% | -6.4% |
| ITCI | Sell | INTRA-CELLULAR THERAPIES INC | $154,912,000 | -19.0% | 3,329,279 | -0.6% | 2.22% | -17.8% |
| AXNX | Sell | AXONICS INC | $154,489,000 | +17.8% | 2,193,200 | -5.2% | 2.22% | +19.6% |
| ABT | Sell | ABBOTT LABS | $151,899,000 | -11.2% | 1,569,851 | -0.3% | 2.18% | -9.8% |
| UNH | Sell | UNITEDHEALTH GROUP INC | $149,873,000 | -3.4% | 296,754 | -1.8% | 2.15% | -1.9% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $147,331,000 | +2.7% | 3,804,047 | -1.2% | 2.11% | +4.2% |
| SAGE | Sell | SAGE THERAPEUTICS INC | $116,332,000 | +21.1% | 2,970,678 | -0.1% | 1.67% | +23.0% |
| AGIO | Sell | AGIOS PHARMACEUTICALS INC | $114,783,000 | +27.4% | 4,058,792 | -0.1% | 1.65% | +29.4% |
| JAZZ | Sell | JAZZ PHARMACEUTICALS PLC | $109,810,000 | -23.3% | 823,839 | -10.2% | 1.58% | -22.1% |
| MYOV | Sell | MYOVANT SCIENCES LTD | $106,191,000 | +44.3% | 5,912,639 | -0.1% | 1.52% | +46.5% |
| SYK | Sell | STRYKER CORPORATION | $96,598,000 | +1.7% | 476,932 | -0.1% | 1.39% | +3.2% |
| ANTM | Sell | ELEVANCE HEALTH INC | $91,979,000 | -8.6% | 202,492 | -2.9% | 1.32% | -7.2% |
| PODD | Sell | INSULET CORP | $85,785,000 | +1.9% | 373,953 | -3.2% | 1.23% | +3.4% |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $83,557,000 | -2.2% | 755,898 | -33.7% | 1.20% | -0.7% |
| OPCH | Sell | OPTION CARE HEALTH INC | $82,740,000 | +3.1% | 2,629,172 | -8.9% | 1.19% | +4.7% |
| MOH | Sell | MOLINA HEALTHCARE INC | $79,356,000 | +14.3% | 240,590 | -3.1% | 1.14% | +16.1% |
| SWAV | Sell | SHOCKWAVE MEDICAL INC | $76,784,000 | +8.3% | 276,132 | -25.5% | 1.10% | +10.0% |
| BDX | Sell | BECTON DICKINSON & CO | $74,612,000 | -11.8% | 334,838 | -2.4% | 1.07% | -10.4% |
| INSP | Sell | INSPIRE MEDICAL SYSTEMS INC | $71,262,000 | -4.2% | 401,768 | -1.3% | 1.02% | -2.7% |
| DXCM | Sell | DEXCOM INC | $69,301,000 | +0.1% | 860,460 | -7.3% | 1.00% | +1.7% |
| INSM | Sell | INSMED INC | $69,245,000 | -3.0% | 3,214,704 | -11.2% | 0.99% | -1.6% |
| APLS | Sell | APELLIS PHARMACEUTICALS INC | $68,809,000 | +26.1% | 1,007,444 | -16.5% | 0.99% | +28.1% |
| EVH | Sell | EVOLENT HEALTH INCcl a | $67,155,000 | +8.3% | 1,869,055 | -7.4% | 0.96% | +10.0% |
| HUM | Sell | HUMANA INC | $65,115,000 | -4.3% | 134,206 | -7.6% | 0.94% | -2.7% |
| HCA | Sell | HCA HEALTHCARE INC | $52,525,000 | +6.8% | 285,789 | -2.4% | 0.75% | +8.3% |
| CI | Sell | CIGNA CORP NEW | $52,359,000 | +2.6% | 188,701 | -2.6% | 0.75% | +4.2% |
| MDT | Sell | MEDTRONIC PLC | $49,736,000 | -14.2% | 615,926 | -4.6% | 0.71% | -12.8% |
| EXEL | Sell | EXELIXIS INC | $41,921,000 | -24.8% | 2,673,500 | -0.2% | 0.60% | -23.6% |
| CNC | Sell | CENTENE CORP DEL | $41,118,000 | -11.0% | 528,440 | -3.2% | 0.59% | -9.6% |
| ABMD | Sell | ABIOMED INC | $40,867,000 | -2.6% | 166,355 | -1.9% | 0.59% | -1.0% |
| ACCD | Sell | ACCOLADE INC | $40,790,000 | +51.6% | 3,571,870 | -1.7% | 0.58% | +53.9% |
| GMED | Sell | GLOBUS MEDICAL INCcl a | $38,551,000 | +4.6% | 647,163 | -1.4% | 0.55% | +6.1% |
| HALO | Sell | HALOZYME THERAPEUTICS INC | $36,792,000 | -13.9% | 930,500 | -4.2% | 0.53% | -12.6% |
| OMCL | Sell | OMNICELL INC | $36,055,000 | -25.6% | 414,284 | -2.7% | 0.52% | -24.5% |
| PEN | Sell | PENUMBRA INC | $35,981,000 | +50.0% | 189,774 | -1.5% | 0.52% | +52.2% |
| IDXX | Sell | IDEXX LABORATORIES INC | $35,454,000 | -12.7% | 108,822 | -6.0% | 0.51% | -11.3% |
| PFE | Sell | PFIZER INC | $33,577,000 | -23.4% | 767,300 | -8.2% | 0.48% | -22.1% |
| PACB | Sell | PACIFIC BIOSCIENCES OF CALIF | $31,577,000 | +19.8% | 5,439,551 | -8.8% | 0.45% | +21.8% |
| HRMY | Sell | HARMONY BIOSCIENCES HOLDINGS | $29,107,000 | -15.0% | 657,188 | -6.4% | 0.42% | -13.6% |
| IQV | Sell | IQVIA HOLDINGS INC | $29,024,000 | -20.7% | 160,227 | -5.0% | 0.42% | -19.3% |
| ESPR | Sell | ESPERION THERAPEUTICS INC | $28,309,000 | +5.1% | 4,225,264 | -0.2% | 0.41% | +6.6% |
| ZBH | Sell | ZIMMER BIOMET HOLDINGS INC | $27,734,000 | -0.8% | 265,270 | -0.3% | 0.40% | +0.8% |
| BEAM | Sell | BEAM THERAPEUTICS INC | $27,237,000 | +22.9% | 571,721 | -0.2% | 0.39% | +24.9% |
| KZR | Sell | KEZAR LIFE SCIENCES INC | $26,097,000 | +4.0% | 3,031,000 | -0.1% | 0.38% | +5.6% |
| VEEV | Sell | VEEVA SYSTEMS INC | $25,984,000 | -22.3% | 157,591 | -6.6% | 0.37% | -21.0% |
| LEGN | Sell | LEGEND BIOTECH CORPsponsored ads | $25,519,000 | -26.4% | 625,461 | -0.8% | 0.37% | -25.3% |
| Sell | PROCEPT BIOROBOTICS CORP | $24,431,000 | +25.5% | 589,262 | -1.0% | 0.35% | +27.6% | |
| ADPT | Sell | ADAPTIVE BIOTECHNOLOGIES | $23,351,000 | -18.4% | 3,279,620 | -7.3% | 0.34% | -17.3% |
| AXSM | Sell | AXSOME THERAPEUTICS INC | $22,155,000 | -29.2% | 496,524 | -39.2% | 0.32% | -28.1% |
| CVS | Sell | CVS HEALTH CORP | $21,469,000 | +1.1% | 225,114 | -1.8% | 0.31% | +2.7% |
| COO | Sell | COOPER COS INC | $21,459,000 | -15.9% | 81,313 | -0.2% | 0.31% | -14.7% |
| HZNP | Sell | HORIZON THERAPEUTICS PUB L | $18,681,000 | -30.6% | 301,850 | -10.5% | 0.27% | -29.5% |
| RMD | Sell | RESMED INC | $18,471,000 | +3.8% | 84,612 | -0.3% | 0.26% | +5.6% |
| PRVA | Sell | PRIVIA HEALTH GROUP INC | $17,542,000 | +15.9% | 515,030 | -0.9% | 0.25% | +17.8% |
| BAX | Sell | BAXTER INTL INC | $17,211,000 | -41.5% | 319,548 | -30.2% | 0.25% | -40.6% |
| PHR | Sell | PHREESIA INC | $16,980,000 | -0.2% | 666,419 | -2.0% | 0.24% | +1.7% |
| ILMN | Sell | ILLUMINA INC | $16,394,000 | +2.4% | 85,927 | -1.1% | 0.24% | +4.0% |
| HOLX | Sell | HOLOGIC INC | $16,221,000 | -13.6% | 251,412 | -7.2% | 0.23% | -12.1% |
| ALGN | Sell | ALIGN TECHNOLOGY INC | $15,521,000 | -51.5% | 74,939 | -44.6% | 0.22% | -50.7% |
| NVRO | Sell | NEVRO CORP | $12,155,000 | +4.5% | 260,835 | -1.7% | 0.17% | +6.1% |
| REGN | Sell | REGENERON PHARMACEUTICALS | $11,979,000 | +14.3% | 17,389 | -1.9% | 0.17% | +16.2% |
| AMGN | Sell | AMGEN INC | $10,187,000 | -17.8% | 45,196 | -11.3% | 0.15% | -16.6% |
| TDOC | Sell | TELADOC HEALTH INC | $9,894,000 | -28.4% | 390,286 | -6.2% | 0.14% | -27.2% |
| TXG | Sell | 10X GENOMICS INC | $7,238,000 | -38.3% | 254,134 | -2.0% | 0.10% | -37.3% |
| TFX | Sell | TELEFLEX INC | $6,342,000 | -73.1% | 31,480 | -67.2% | 0.09% | -72.8% |
| SGEN | Sell | SEAGEN INC | $5,874,000 | -32.8% | 42,926 | -13.1% | 0.08% | -32.3% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $4,535,000 | -25.8% | 53,493 | -27.5% | 0.06% | -24.4% |
| GH | Sell | GUARDANT HEALTH INC | $3,342,000 | +17.4% | 62,083 | -12.0% | 0.05% | +20.0% |
| OLK | Sell | OLINK HOLDING ABsponsored ads | $2,799,000 | -21.7% | 230,522 | -2.0% | 0.04% | -21.6% |
| AZN | Sell | ASTRAZENECA PLCsponsored adr | $2,457,000 | -57.3% | 44,400 | -49.0% | 0.04% | -56.8% |
| RCUS | Sell | ARCUS BIOSCIENCES INC | $2,184,000 | -4.3% | 83,500 | -7.3% | 0.03% | -3.1% |
| ABC | Sell | AMERISOURCEBERGEN CORP | $1,612,000 | -12.3% | 11,910 | -8.4% | 0.02% | -11.5% |
| NPCE | Sell | NEUROPACE INC | $1,456,000 | -42.1% | 388,368 | -23.5% | 0.02% | -41.7% |
| VRDN | Sell | VIRIDIAN THERAPEUTICS INC | $946,000 | +66.8% | 46,100 | -5.9% | 0.01% | +75.0% |
| INBX | Sell | INHIBRX INC | $781,000 | -10.1% | 43,500 | -43.2% | 0.01% | -8.3% |
| LH | Sell | LABORATORY CRP OF AMER HLDGS | $799,000 | -19.8% | 3,900 | -8.2% | 0.01% | -21.4% |
| Sell | CARIBOU BIOSCIENCES INC | $699,000 | +83.0% | 66,300 | -5.7% | 0.01% | +100.0% | |
| XNCR | Sell | XENCOR INC | $660,000 | -9.0% | 25,400 | -4.2% | 0.01% | -10.0% |
| BMY | Sell | BRISTOL-MYERS SQUIBB CO | $502,000 | -73.8% | 7,062 | -71.6% | 0.01% | -74.1% |
| NKTR | Sell | NEKTAR THERAPEUTICS | $47,000 | -56.9% | 14,800 | -48.6% | 0.00% | -50.0% |
| ZTS | Sell | ZOETIS INCcl a | $36,000 | -58.1% | 246 | -51.1% | 0.00% | 0.0% |
| SLN | Exit | SILENCE THERAPEUTICS PLCads | $0 | – | -30,483 | -100.0% | -0.01% | – |
| ARCT | Exit | ARCTURUS THERAPEUTICS HLDGS | $0 | – | -39,550 | -100.0% | -0.01% | – |
| KURA | Exit | KURA ONCOLOGY INC | $0 | – | -63,700 | -100.0% | -0.02% | – |
| NVCR | Exit | NOVOCURE LTD | $0 | – | -25,300 | -100.0% | -0.02% | – |
| RARE | Exit | ULTRAGENYX PHARMACEUTICAL IN | $0 | – | -31,000 | -100.0% | -0.03% | – |
| SNY | Exit | SANOFIsponsored adr | $0 | – | -42,300 | -100.0% | -0.03% | – |
| PCRX | Exit | PACIRA BIOSCIENCES INC | $0 | – | -51,936 | -100.0% | -0.04% | – |
| ALKS | Exit | ALKERMES PLC | $0 | – | -107,200 | -100.0% | -0.04% | – |
| HCAT | Exit | HEALTH CATALYST INC | $0 | – | -424,611 | -100.0% | -0.09% | – |
| ONEM | Exit | 1LIFE HEALTHCARE INC | $0 | – | -836,190 | -100.0% | -0.09% | – |
| RDUS | Exit | RADIUS HEALTH INC | $0 | – | -8,796,538 | -100.0% | -1.29% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- BB Biotech AG #1
- Bellevue Asset Management AG #2
- Bellevue Asset Management (UK) Ltd. #3
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IONIS PHARMACEUTICALS INC | 31 | Q3 2023 | 9.3% |
| Vertex Pharmaceuticals Incorporated | 31 | Q3 2023 | 5.9% |
| NEUROCRINE BIOSCIENCES INC | 31 | Q3 2023 | 5.7% |
| Incyte Corporation | 31 | Q3 2023 | 5.4% |
| INTUITIVE SURGICAL INC | 31 | Q3 2023 | 4.7% |
| ABBOTT LABS | 31 | Q3 2023 | 4.6% |
| ELEVANCE HEALTH INC | 31 | Q3 2023 | 4.3% |
| UnitedHealth Group Incorporated | 31 | Q3 2023 | 3.6% |
| ALNYLAM PHARMACEUTICALS INC | 31 | Q3 2023 | 3.7% |
| Boston Scientific Corporation | 31 | Q3 2023 | 2.5% |
View Bellevue Group AG's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13G | 2023-02-14 |
| SC 13G | 2023-02-14 |
| 13F-HR | 2022-11-14 |
View Bellevue Group AG's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.